Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides

Croatian Medical Journal

Volumn 46, Issue 3, 2005, Pages 458-462

  Copur, M Sitki ^a,b   Deshpande, Anita ^a   Mleczko, Kris ^a   Norvell, Max ^a   Hrnicek, Gordon J ^a   Woodward, Suzette ^a   Frankforter, Scott ^a   Mandolfo, Natalie ^a   Fu, Kai ^a   Chan, Wing C ^b  

^a Saint Francis Medical Center Grand Island   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BEXAROTENE; CHLORMETHINE; CORTICOSTEROID; PENTOSTATIN; STEROID;

ADULT; ARTICLE; B CELL LYMPHOMA; BREAST; CASE REPORT; CLINICAL FEATURE; CUTANEOUS B CELL LYMPHOMA; CUTANEOUS T CELL LYMPHOMA; DISEASE COURSE; EPSTEIN BARR VIRUS; ERYTHRODERMA; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; MYCOSIS FUNGOIDES; NONHODGKIN LYMPHOMA; PROGNOSIS; SKIN LYMPHOMA; SKIN NODULE; TREATMENT OUTCOME;

ACYCLOVIR; ADMINISTRATION, TOPICAL; ANTIVIRAL AGENTS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, B-CELL; MIDDLE AGED; MYCOSIS FUNGOIDES; SKIN NEOPLASMS;

EID: 21044443426     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Connors JM, Hsi ED, Foss FM. Lymphoma of the skin. Hematology (Am Soc Hematol Educ Program). 2002;263-82.
2. Querfeld C, Guitart J, Kuzel TM, Rosen ST. Primary cutaneous lymphomas: a review with current treatment options. Blood Rev. 2003;17:131-42.
3. Tuyp E, Burgoyne A, Aitchison T, MacKie R. A case-control study of possible causative factors in mycosis fungoides. Arch Dermatol. 1987;123:196-200.
4. Nagore E, Ledesma E, Collado C, Oliver V, Perez-Perez A, Aliaga A. Detection of Epstein-Barr virus and human herpesvirus 7 and 8 genomes in primary cutaneous T- and B-cell lymphomas. Br J Dermatol. 2000;143:320-3.
5. Wagner M, Rose VA, Linder R, Schulze HJ, Krueger GR. Human pathogenic virus-associated pseudolymphomas and lymphomas with primary cutaneous manifestation in humans and animals. Clin Infect Dis. 1998;27:1299-308.
6. Viguier M, Rivet J, Agbalika F, Kerviler E, Brice P, Dubertret L, et al. B-cell lymphomas involving the skin associated with hepatitis C virus infection. Int J Dermatol. 2002;41:577-82.
7. Weiss VC, Barsky GJ, Solomon LM. Cutaneous T-lymphocyte lymphoma in association with multiple myeloma. Arch Dermatol. 1984;120:499-501.
8. Allue L, Domingo A, Moreno A, Crespo N, Marcoval J, Peyri J. Simultaneous occurrence of cutaneous T cell iymphoma and low-grade B cell lymphoproliferative diseases. A report of two cases. J Am Acad Dermatol. 1990;23(4 Pt 1):677-81.
9. Hu E, Weiss LM, Warnke R, Sklar J. Non-Hodgkin's lymphoma containing both B and T cell clones. Blood. 1987;70:287-92.
10. Grange F, Avril MF, Esteve E, Joly P, Bosq J, de Murets A, et al. Coexistent cutaneous T-cell lymphoma and B-cell malignancy. French Study Group on Cutaneous Lymphomas. J Am Acad Dermatol. 1994;31(5 Pt 1):724-31.
11. Hull PR, Saxena A. Mycosis fungoides and chronic lymphocytic leukaemia - composite T-cell and B-cell lymphomas presenting in the skin. Br J Dermatol. 2000;143:439-44.
12. Kikuchi A, Anzai H, Kosuge H, Naka W, Nishikawa T. Aggressive B-cell lymphoma induced by Epstein-Barr virus infection in erythrodermic cutaneous T-cell lymphoma. Br J Dermatol. 1997;136:124-8.
13. Sausville EA, Eddy JL, Makuch RW, Fischmann AB, Schechter GP, Matthews M, et al. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sezary syndrome. Definition of three distinctive prognostic groups. Ann Intern Med. 1988;109:372-82.
14. Hopwood P, Crawford DH. The role of EBV in post-transplant malignancies: a review. J Clin Pathol. 2000;53:248-54.
15. Mozzanica N, Cattaneo A, Fracchiolla N, Boneschi V, Berti E, Gronda E, et al. Posttransplantation cutaneous B-cell lymphoma with monoclonal Epstein-Barr virus infection, responding to acyclovir and reduction in immunosuppression. J Heart Lung Transplant. 1997;16:964-8.
16. Fardet L, Blanche S, Brousse N, Bodemer C, Fraitag S. Cutaneous EBV-related lymphoproliferative disorder in a 15-year-old boy with AIDS: an unusual clinical presentation. J Pediatr Hematol Oncol. 2002;24:666-9.
17. Tournadre A, D'Incan M, Dubost JJ, Franck F, Dechelotte P, Souteyrand P, et al. Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate. Mayo Clin Proc. 2001;76:845-8.
18. Greene MH, Pinto HA, Kant JA, Siler K, Vonderheid EC, Lamberg SI, et al. Lymphomas and leukemias in the relatives of patients with mycosis fungoides. Cancer. 1982;49:737-41.
19. Olsen EA, Delzell E, Jegasothy BV. Second malignancies in cutaneous T cell lymphoma. J Am Acad Dermatol. 1984;10(2 Pt 1):197-204.
20. Salahuddin SZ, Markham PD, Lindner SG, Gootenberg J, Popovic M, Hemmi H, et al. Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I. Science. 1984;223:703-7.
21. Saed G, Fivenson DP, Naidu Y, Nickoloff BJ. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile. J Invest Dermatol. 1994;103:29-33.
22. Lee BN, Duvic M, Tang CK, Bueso-Ramos C, Estrov Z, Reuben JM. Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma. Clin Diagn Lab Immunol. 1999;6:79-84.
23. Tartour E, Fossiez F, Joyeux I, Galinha A, Gey A, Claret E, et al. Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res. 1999;59:3698-704.
24. List AF, Greco FA, Vogler LB. Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus. J Clin Oncol. 1987;5:1673-89.
25. Gottschalk S, Rooney CM, Heslop HE. Post-transplant lymphoproliferative disorders. Annu Rev Med. 2005;56:29-44.
26. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Sakamoto K, Purtilo DT, Balfour HH Jr, et al. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med. 1982;306:913-8.
27. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Sakamoto K, Purtilo DT, Balfour HH, Jr, Simmons RL, Najarian JS. Acyclovir therapy of Epstein-Barr virus induced posttransplant lymphoproliferative disease. Transplant Proc. 1985;17:89-92.